Mary Dillhoff
Papers
1
Total Citations
10
H-Index
1
About
Mary Dillhoff is a leading surgical oncologist whose research focuses on advancing the treatment of hepatobiliary and pancreatic malignancies, with a particular emphasis on cholangiocarcinoma. Her major contributions lie in the comparative effectiveness of surgical approaches for complex liver cancers. In her highly cited 2024 study, Dillhoff and her team provided critical evidence by analyzing oncologic outcomes across laparoscopic, robotic, and open surgical techniques for intrahepatic and perihilar cholangiocarcinoma. This work, which has already garnered 10 citations, offers surgeons and patients a data-driven framework for selecting the optimal minimally invasive or open approach, directly impacting clinical decision-making and postoperative survival. Beyond this landmark paper, Dillhoff is recognized for her expertise in multimodal management of pancreatic cancer and her role in large, multi-institutional trials that shape national treatment guidelines. Her research consistently bridges the gap between technical innovation and real-world patient outcomes, making her a pivotal figure in the evolution of hepatopancreatobiliary surgery.
Research Focus
Key Achievements
Top Papers
- 1